Khuong Duy Pharmaceutical is a rising star among Vietnam’s mid-sized pharmaceutical firms, known for its focus on trading and wholesale distribution of medicine and supplements. It operates a lean, efficient structure concentrating on high-demand therapeutic categories.

The company posted USD 86.98 million in revenue and USD 14.46 million in net profit in 2023. Its asset base totaled just USD 23.97 million, while equity was USD 14.94 million, underscoring its capital efficiency and disciplined cost management.

Though smaller in scale, Khuong Duy achieved one of the highest profitability ratios among the top 10. VBI recognized it for operational efficiency and high return on sales, placing it in the top five nationwide.

Commencing operations on 25 July 1995, it specializes in the wholesale of other household products and provides a wide array of products and services. The company's sales are uptrend. The financial statement reveals that the company's charter capital is VND 50,000,000,000. KHUONG DUY PHARMACEUTICAL JOINT STOCK COMPANY is adequately funded to sustain its business activities. Strategic direction is overseen by NGUYEN T.V.H and NGUYEN T.M.D, who play a pivotal role in shaping company policies.